Navigation Links
Texas Fertility Center Responds to Dateline Story on IVF Lab Mix-Up
Date:1/10/2013

Austin, TX (PRWEB) January 10, 2013

Texas Fertility Center (TFC), a pioneer in assisted reproductive technologies, has rigid laboratory protocols in place to minimize the likelihood that the scenario that occurred in an Ohio IVF lab could ever happen in it's IVF laboratory.

The Dateline story “Inconceivable” aired Sunday, Jan. 6, 2013 and detailed how a mix-up occurred in a fertility lab resulting in transfer of embryos to the wrong patient during an IVF cycle. In 2009, Carolyn Savage, her husband Sean by her side, received the embryo belonging to another couple during the embryo transfer stage of IVF. Carolyn became pregnant, and soon learned of the error which DNA testing confirmed. Both women, the biological and gestational mothers, then began a long process of grief, resolution and healing.

After watching the Dateline episode, Texas Fertility Center Reproductive Endocrinologist Dr. Kaylen Silverberg immediately responded with an open letter to TFC patients explaining how TFC does everything humanly possible to prevent mistakes in its certified IVF laboratory.

“There are many misconceptions associated with infertility, and I want to ensure that people understand the extraordinary high standards that are used to govern reputable, certified fertility labs,” Dr. Silverberg says. “I liken this ‘Inconceivable’ story to a plane crash. While the news is tragic and shocking, it’s not representative of the standard of care that occurs every day in reproductive medicine.”

According to the Centers for Disease Control and Prevention (CDC), approximately 150,000 fresh IVF cycles take place in the US every year. That translates to approximately 1.5 million IVF cycles in the past decade alone. The fact that mistakes such as this one are such rare events serves as testimony to the exacting standards and safeguards that reputable IVF program have put in place.

The Texas Fertility Center laboratory policies and procedures are regularly documented, internally scrutinized and externally inspected by the College of American Pathologists (CAP), as well as the Federal Food and Drug Administration (FDA).

“Our fertility laboratory maintains the highest quality, and several of our embryologists actually serve as CAP inspectors – inspecting other laboratories around the country,” adds Dr. Silverberg.

Texas Fertility Center details on its website an exhaustive process for protecting individuals and couples from human error during embryo transfer. Read more about Texas Fertility Center and Austin IVF lab protocols and long-standing safeguards here.

For example, only one patient's gametes (embryos, egg or sperm) can be in each lab area at a time. Incubators are labeled by patient name and each patient’s identity is confirmed before and after the gametes are removed or returned to the incubator.

“We hope that television viewers who saw the Dateline piece and are currently undergoing fertility treatment understand the extreme safeguards in place at accredited fertility labs,” says Tom Turner, Chief Embryologist with Texas Fertility Center’s partner lab, Austin IVF. “Proper embryo identification and error prevention protocols, coupled with a rigorous CAP management and accountability system should reassure patients that their embryos are in capable hands during oocyte (egg) retrieval and transfer.”

Texas Fertility Center and its fully accredited laboratory partner, Austin IVF, maintain the highest standards and take every possible precaution to ensure that IVF lab mix-ups do not devastate a couple undergoing fertility treatment.

“Not on our watch,” says Dr. Silverberg.

About Texas Fertility Center
Texas Fertility Center (TFC), one of the nation’s leading full-service infertility practices, provides advanced Infertility and Reproductive Endocrinology services to patients throughout Texas, the Southwestern United States, and the Americas. Since 1980, TFC has been recognized nationally for outstanding pregnancy rates, cutting-edge laboratory procedures, and innovative research programs. For more information, please visit http://www.txfertility.com.

Read the full story at http://www.prweb.com/releases/2013/IVF/prweb10302449.htm.


'/>"/>
Source: PRWeb
Copyright©2012 Vocus, Inc.
All rights reserved

Related biology technology :

1. Dallas-Fort Worth Fertility Associates Celebrates First Birth in North Texas from Advanced Trophectoderm Biopsy Screening Technology
2. Time bomb: Military ordnance in Gulf poses threat to shipping, says Texas A&M proffesor
3. Texas Teacher May Be Among First Lone Star Astronauts
4. Why Texas is #1 in Business: Local BioTech Company Expands
5. Texas Medical Center, the largest concentration of medical research, educational and healthcare organizations in the world, announces the first Houston Stem Cell Summit to highlight the latest stem cell research and commercialization efforts
6. NSBRI Renews Space Life Sciences Graduate Programs at MIT, Texas A&M
7. Worlds smallest semiconductor laser created by University of Texas scientists
8. United States Rocket Academy Welcomes XCOR Aerospace to Texas
9. Mining cleanup benefits from Texas A&M expertise
10. CEM President and CEO Delivers Commencement Address at the 2012 University of Texas at Austin Chemistry and Biochemistry Department Graduation
11. CuraLase Expands with New Franchise in Texas
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:6/23/2016)... - FACIT has announced the creation of a ... Propellon Therapeutics Inc. ("Propellon" or "the Company"), to ... of first-in-class WDR5 inhibitors for the treatment of ... an exciting class of therapies, possessing the potential ... patients. Substantial advances have been achieved with the ...
(Date:6/23/2016)... June, 23, 2016  The Biodesign Challenge (BDC), a ... ways to harness living systems and biotechnology, announced its ... in New York City . ... students, showcased projects at MoMA,s Celeste Bartos Theater during ... , MoMA,s senior curator of architecture and design, and ...
(Date:6/23/2016)... June 23, 2016 Apellis Pharmaceuticals, Inc. ... clinical trials of its complement C3 inhibitor, APL-2. ... multiple ascending dose studies designed to assess the ... subcutaneous injection in healthy adult volunteers. ... as a single dose (ranging from 45 to ...
(Date:6/23/2016)... ... June 23, 2016 , ... Regulatory Compliance ... consulting, provides a free webinar on Performing Quality Investigations: Getting to ... 12pm CT at no charge. , Incomplete investigations are still a major concern ...
Breaking Biology Technology:
(Date:5/12/2016)... , May 12, 2016 WearablesResearch.com ... just published the overview results from the Q1 wave ... the recent wave was consumers, receptivity to a program ... data with a health insurance company. "We ... to share," says Michael LaColla , CEO of ...
(Date:4/28/2016)... April 28, 2016 First quarter 2016:   ... 966% compared with the first quarter of 2015 The ... 589.1 M (loss: 18.8) and the operating margin was 40% (-13) ... Cash flow from operations was SEK 249.9 M (21.2) ... guidance is unchanged, SEK 7,000-8,500 M. The operating margin ...
(Date:4/15/2016)... 2016  A new partnership announced today will ... decisions in a fraction of the time it ... high-value life insurance policies to consumers without requiring ... Force Diagnostics, rapid testing (A1C, Cotinine and HIV) ... pressure, weight, pulse, BMI, and activity data) available ...
Breaking Biology News(10 mins):